Patheon is a global provider of development and commercial manufacturing services for solid and sterile prescription drugs, offering a wide variety of services and products. SEE AND Read More »

Company Profile

  • Spanish
  • Japanese
  • Italian
  • French
  • Dutch

Patheon is the leading publicly listed provider of drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. The company's strategic vision is to become the industry's best provider of pharmaceutical development and manufacturing services.

Services

Patheon's global manufacturing network includes approximately 6,000 employees providing services at 12 commercial contract manufacturing facilities, and 9 development centers across North America and Europe.

The company enables its customers to bring drug candidates from preclinical stages through to clinical trials, the NDA approval process and, if approved, commercial manufacturing. Patheon's development and commercial manufacturing capabilities cover primarily prescription (Rx) products in solid and sterile dosage forms, as well as specialized capabilities in high potency, controlled/sustained release, and sterile manufacturing, including aseptic filling and lyophilization.

Market Opportunity

The pharmaceutical industry is growing and, compared with other industries, is in the early stages of adopting manufacturing and development outsourcing strategies. Many global pharma, biotech and specialty pharma companies are relying on the services of contract product development and commercial manufacturing companies to help them meet growing demand and bring new drugs to market more quickly.

Patheon is the established leader in this relatively new segment of the pharmaceutical industry. With a wide range of manufacturing capabilities and significant scale in the world's two largest pharmaceutical markets – the United States and Europe – the company is uniquely positioned to serve as a strategic global manufacturing partner to the industry's leading innovators.

Patheon serves approximately 300 clients, including 19 of the 20 largest pharmaceutical companies, 8 of the top 10 biotech companies, and 8 of the 10 largest specialty pharmaceutical companies.

Ask The Experts

James C. Mullen

James C. Mullen
Mr. Mullen is currently Chief Executive Officer of DPx. He joined Patheon Inc. in 2011 as CEO and ha
Read More »

Andrea Como

Andrea Como
Mr. Como oversees our technology transfer and technical business management teams at our sterile and
Read More »

Franco Negron

Franco Negron
Mr. Negron serves as Senior Vice President, North America Commercial Operations and Global Integrati
Read More »

Anil Kane, Ph.D., MBA

Anil Kane, Ph.D., MBA
Dr. Kane has more than 25 years of experience in the science and business of taking molecules throug
Read More »

Ann Newman, Ph.D.

Ann Newman, Ph.D.
Dr. Newman’s expertise is in solid-state chemistry: physical forms, polymorphism, salts, cocrystals,
Read More »

Antonio Magnelli

Antonio Magnelli
Mr. Magnelli serves as Senior Vice President, European Commercial Operations within the global CMO b
Read More »

Kaspar van den Dries, Ph.D.

Kaspar van den Dries, Ph.D.
Based at our Tilburg facility in the Netherlands, Dr. van den Dries leads Patheon’s European researc
Read More »

Mike Lehmann

Mike Lehmann
Mr. Lehmann is currently President, PDS and Interim Head of Drug Product Sales and Marketing of DPx.
Read More »

Robert A. Lipper, Ph.D.

Robert A. Lipper, Ph.D.
Having ushered multiple products to market though the entire development process, Dr. Lipper is an e
Read More »

Bob Zinser, M.S. Chemistry, MBA

Bob Zinser, M.S. Chemistry, MBA
Mr. Zinser offers Patheon customers the advantage of more than 39 years’ experience in pharmaceutica
Read More »

Manja Bouman

Manja Bouman
Ms. Bouman is currently the President, Bio business unit at DPx.
Read More »

Lukas Utiger

Lukas Utiger
Mr. Utiger is currently President, Fine Chemicals and Integrated Offering at DPx. Previously he serv
Read More »

Geoff Glass

Geoff Glass
Mr. Glass was appointed President of Banner Life Sciences™ in 2012. He joined Patheon in 2009 as Sen
Read More »

Joseph A. Fix, MBA, Ph.D.

Joseph A. Fix, MBA, Ph.D.
With 30 years of experience converting discoveries into businesses, Dr. Fix holds 24 patents, includ
Read More »

John S. Kent, Ph.D.

John S. Kent, Ph.D.
With over 35 years of experience, Dr. Kent offers expertise in overcoming development challenges for
Read More »

K. George Mooney, Ph.D.

K. George Mooney, Ph.D.
Dr. Mooney has 35 years’ experience in pharmaceutical sciences and exploratory drug development. He
Read More »

Harry Gill

Harry Gill
Mr. Gill serves as Senior Vice President, Quality and Continuous Improvement at DPx.
Read More »

Laura Parks

Laura Parks
Ms. Parks serves as Sr. Vice President, Corporate Operations and Strategic Initiatives at DPx.
Read More »

Larry Gatlin, Ph.D.

Larry Gatlin, Ph.D.
Dr. Gatlin is an industry veteran with more than 36 years of scientific and leadership experience. H
Read More »

Enrico Corona

Enrico Corona
Since joining Patheon in 2003, Mr. Corona has been vital in the development of new liquid and lyophi
Read More »

Ray Guidotti

Ray Guidotti
Mr. Guidotti serves as Vice President of Global Engineering and Capacity Planning. He joined Patheo
Read More »

Stuart Grant

Stuart Grant
Mr. Grant is currently Chief Financial Officer and Executive Vice President of Finance and IT at DPx
Read More »

Lynn Van Campen, Ph.D.

Lynn Van Campen, Ph.D.
With more than 30 years of drug development experience, Dr. Van Campen is an expert in the establish
Read More »

Geoff Carr, Ph.D.

Geoff Carr, Ph.D.
Dr. Carr offers Patheon customers 36 years of applying analytical science to the creation of pharmac
Read More »

Giuseppe Cassisi, MBA

Giuseppe Cassisi, MBA
With a solid foundation of marketing and sales, and expertise in the licensing of generics and drug
Read More »

Mark A. Staples, Ph.D.

Mark A. Staples, Ph.D.
Having worked 32 years with all early to mid-stage companies, Dr. Staples is an expert at the early
Read More »

Rodney Pearlman, PhD.

Rodney Pearlman, PhD.
An expert in the development of scientific and business strategies for start-ups, Dr. Pearlman bring
Read More »

Rebecca Holland-New

Rebecca Holland-New
Mrs. Holland New serves as Chief HR Officer and Senior Vice President, Human Resources and Corporate
Read More »

Michael Lytton

Michael Lytton
Mr. Lytton is currently General Counsel and Executive Vice President of Corporate Development and St
Read More »

Gordon Marr, Ph.D.

Gordon Marr, Ph.D.
Dr. Marr is an expert in computer-aided analytical method development, optimization and validation f
Read More »

Gary Shope

Gary Shope
Mr. Shope serves as Chief of Staff. Previously, he worked as an international business adviser for t
Read More »

Harry Gill

Harry Gill
Mr. Gill has amassed a broad range of expertise in his 25 years of global pharmaceutical operations
Read More »

Jason Vaughn, Ph.D.

Jason Vaughn, Ph.D.
Dr. Vaughn has expertise in early and preclinical development of liquid, semi-solid and solid dosage
Read More »

Mirko Gabriele, MBA

Mirko Gabriele, MBA
An expert in scale-up and technology transfers, Mr. Gabriele’s 10 years of pharmaceutical industry e
Read More »

Roman Hlodan, Ph.D.

Roman Hlodan, Ph.D.
Dr. Hlodan is an expert in the development of biopharmaceuticals, including analytical method devel
Read More »

Stefano Chiaramonti, Ph.D.

Stefano Chiaramonti, Ph.D.
With 17 years of experience in pharmaceutical development and operations leadership in Europe, and a
Read More »

Stephen Closs

Stephen Closs
Mr. Closs possess more than 23 years of experience in formulation development, tech transfer, scale-
Read More »

Leah Appel, Ph.D.

Leah Appel, Ph.D.
Dr. Appel has over 20 years’ experience in the pharmaceutical industry developing drug delivery tech
Read More »

Tony Pidgeon

Tony Pidgeon
Mr. Pidgeon has nearly three decades of experience in the formulation and process development of ste
Read More »

Bret Berner, Ph.D.

Bret Berner, Ph.D.
Dr. Berner holds more than 40 patents in various areas of drug delivery, but is an internationally r
Read More »

William E. Weiser, Ph.D.

William E. Weiser, Ph.D.
Dr. Weiser is an expert in analytical method development and validation for APIs and drug products.
Read More »

View All »

Knowledge Library


Please fill the below form to access requested content

First Name

Last Name

Company

Title

Email

Phone

Address Line 1

Address Line 2

City

State / Province

Zip/ Postal Code

Country

Submit